| ¿µ¹® | amino acids | ÇÑ±Û | ¾Æ¹Ì³ë»ê |
|---|---|---|---|
| ¼³¸í | ¾Æ¹Ì³ë±â(£NH3)¿Í Ä«¸£º¹½Ç±â(£COOH)¸¦ °¡Áö°í ÀÖ´Â ¸ðµç À¯±â¹°Áú. ´Ü¹éÁúÀ» ÀÌ·ç´Â ±âº»´ÜÀ§°¡ µÈ´Ù. Áï ´Ü¹éÁúÀº ¾Æ¹Ì³ë»êÀÌ ¿¬°áµÇ¾î¼ ÀÌ·ç´Â °ÍÀÌ´Ù. ÀÎü¿¡¼´Â ¾Æ¹Ì³ë»êÀÌ ´Ü¹éÁúÀÇ ±âº»´ÜÀ§°¡ µÇ´Â °Í¿Ü¿¡ ½Å°æ¼¼Æ÷¿Í ½Å°æ¼¼Æ÷°¡ ¼·Î ¿¬¶ôÀ» ÁÖ°í ¹Þ´Âµ¥ ¾²ÀÌ´Â ½Å°æÀü´Þ¹°Áú·Î¼ÀÇ ¿ªÇÒµµ ÇÑ´Ù. »ç¶÷ÀÇ ´Ü¹éÁúÀº 20°¡ÁöÀÇ ¾Æ¹Ì³ë»êÀ¸·Î ±¸¼ºµÈ´Ù. Áï »ç¶÷¿¡ ÀÖ¾î¼ ´Ü¹éÁúÀ» ÇÕ¼ºÇÏ´Â µ¥´Â 20°¡ÁöÀÇ ¾Æ¹Ì³ë»êÀÌ ÇÊ¿äÇÏ´Ù. ¿©±â¿¡¼ 11°¡Áö´Â ÀÎü³»¿¡¼ Á÷Á¢ ÇÕ¼ºÇÒ ¼ö ÀÖÁö¸¸ ³ª¸ÓÁö 9°¡Áö´Â ÇÕ¼ºÇÒ ¼ö ¾ø°í ¹Ýµå½Ã À½½Ä¹°¿¡¼ ¼·ÃëÇØ¾ß ÇÑ´Ù. À̰ÍÀ» Çʼö¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. |
||
| MLC | minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen... |
|---|---|
| GnRH | Gonadotropin Releasing Hormone [HP 1898, 2034] = LHRH = Go... |
| CAA | carotid audiofrequency analysis; cerebral amyloid angiopathy; circulating anodic antigen; Clean Air ... |
| TAGH | triiodothyronine, amino acids, glucagon, and heparin |
| AAN | AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o... |
| HETE's | Mono-hydroxy-eicosatetraenoic acids |
|---|---|
| LCP | Long Chain Polyunsaturated fatty acids |
| LCFA | Long chain fatty acids |
| MCFA | Medium-chain fatty acids |
| MUFA | Monounsaturated fatty acids |
| chelate | 1. To effect chelation. 2. Pertaining to chelation. 3. A complex formed through chelation. (05 Mar 2000) |
|---|---|
| amino acids | Organic compounds that generally contain an amino (-nh2) and a carboxyl (-cooh) group. Twenty alpha-amino acids are the subunits which are polymerised to form proteins. (12 Dec 1998) |
| amino acids, branched-chain | Amino acids which have a branched carbon chain. (12 Dec 1998) |
| amino acids, cyclic | A class of amino acids characterised by a closed ring structure. (12 Dec 1998) |
| amino acids, peptides, and proteins | Amino acids and chains of amino acids connected by peptide linkages. (12 Dec 1998) |
| essential amino acids | Alpha-amino acids nutritionally required by an organism and which must be supplied in its diet (i.e., cannot be synthesised by the organism) either as free amino acid or in proteins. (05 Mar 2000) |
| excitatory amino acids | Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear. (12 Dec 1998) |
| aluminum magnesium silicate | An antacid. Synonym: aluminum magnesium silicate. (05 Mar 2000) |
| calcium magnesium-atpase | <enzyme> An enzyme that catalyses the hydrolysis of ATP and is activated by millimolar concentrations of either calcium or magnesium. Unlike calcium-transporting atpase it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. Registry number: EC 3.6.1.- (12 Dec 1998) |
| calcium magnesium dependent endodeoxyribonuclease | <enzyme> Similar in action but different from dnase i Registry number: EC 3.1.21.- Synonym: ca mg dnase, ca(2+)+mg(2+) dnase, calcium-magnesium endonuclease, ca-mg endonuclease (26 Jun 1999) |
| magnesium | <chemical, element> An essential divalent cation. The major role is as the chelated ion in ATP and presumably other triphosphonucleotides. The magnesium ATP complex is the sole biologically active form of ATP. The other essential role of magnesium is as the central ion of chlorophyll. Cellular concentration is less than 5mM. Serum concentration approximately 1mM. Pharmacologic action: Hypomagnesemia can cause refractory ventricular fibrillation or ventricular tachycardia. Uses: known hypomagnesemic states - suspect hypomagnesmia in alcoholics, chronic disease states, or others with poor nutrition; treatment of choice for Torsade de Pointes. Dose: 1-2 grams IV push for cardiac arrest, over 1 to 2 minutes for Torsades, and over 5 to 60 minutes for acute myocardial infarction. Potential complications: Transient flushing and diaphoresis, sinus bradycardia, hypotension, hyporeflexia and paralysis with overdose. Abbreviation: Mg (15 Mar 2000) |
| magnesium aluminum silicate | An antacid. Synonym: aluminum magnesium silicate. (05 Mar 2000) |
| magnesium bacteriopheophytinate | <microbiology, plant biology> Varieties of chlorophyll (bacteriochlorophylls a, b, c, d, e and g) found in photosynthetic bacteria and differing from plant chlorophyll in the substituents around the tetrapyrrole nucleus of the molecule and in the absorption spectra. (18 Nov 1997) |
| magnesium benzoate | Has been used in gout and rheumatoid arthritis. (05 Mar 2000) |
| magnesium-bicarbonate ATPase | <enzyme> Aspect of EC 3.6.1.3 Registry number: EC 3.6.1.- Synonym: mg-hco3-atpase, atpase, magnesium-bicarbonate (26 Jun 1999) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|